KORU Medical reports 22% FY2025 revenue growth; positive adjusted EBITDA; initiates FY2026 guidance

KORU Medical Systems, Inc.

Q4 2025 net revenue $10.9M (+23% YoY); FY2025 net revenue $41.1M (+22% YoY).
International Core revenue grew 80% in FY2025; Domestic Core grew 11%.
FY2025 net loss narrowed 57% to $2.6M ($0.06 loss per share); positive adjusted EBITDA of $0.6M.
Cash and cash equivalents $8.9M at Dec 31, 2025; used only $0.7M cash in FY2025.
FY2026 guidance: net revenue $47.5–$50.0M (15–22% growth); positive adjusted EBITDA and positive cash flow.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

KORU Medical Systems, Inc. reported full year ended December 31, 2025 results: revenue $41.1 million, net income $2.6 million or ($0.06) per diluted share, EPS ($0.06) per diluted share. Guidance initiated.

Period: full year ended December 31, 2025
Revenue: $41.1 million
Net income: $2.6 million or ($0.06) per diluted share
EPS: ($0.06) per diluted share
Guidance: initiated
Result: reported results

Exact text from the filing

Total net revenues increased $7.5 million, or 22.2%, to $41.1 million, for the year ended December 31, 2025, as compared with the same period last year.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

KORU Medical Systems, Inc. reported fourth quarter ended December 31, 2025 results: revenue $10.9 million, net income $0.5 million or ($0.01) per diluted share, EPS ($0.01) per diluted share.

Period: fourth quarter ended December 31, 2025
Revenue: $10.9 million
Net income: $0.5 million or ($0.01) per diluted share
EPS: ($0.01) per diluted share
Result: reported results

Exact text from the filing

quarter and full year ended December 31, 2025. The Company also initiated guidance for the full year 2026. Recent Highlights ● Fourth quarter 2025 net revenues grew 23% to $10.9 million; Full year 2025 net revenues grew 22% to $41.1 million ● Full year 2025 gross profit grew 20% to $25.6 million with gross margin of 62.3% ● Full year 2025 net loss of ($2.6)

View on SEC.gov

Browse all earnings releases →

KORU Medical Systems, Inc. filing history →

Source: SEC EDGAR

accession 0001161697-26-000051

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.